| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $254.6M | -14.7% |
| R&D Expense | $17.3M | -6.4% |
| SG&A Expense | $37.7M | +6.7% |
| Operating Income | -$23.7M | +60.7% |
| Pre-tax Income | -$31.1M | +50.9% |
| Income Tax | -$1.8M | -1461.2% |
| Net Income | -$29.3M | +53.7% |
| EPS (Basic) | -$1.80 | -133.8% |
| EPS (Diluted) | -$1.80 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.4M | -40.3% |
| Accounts Receivable | $46.5M | -17.7% |
| Current Assets | $66.0M | -15.9% |
| Total Assets | $93.6M | -16.3% |
| Current Liabilities | $64.7M | +31.4% |
| Long-term Debt | $35.6M | +16.7% |
| Total Liabilities | $68.7M | -11.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.1M | -273.3% |
| Capital Expenditures | $13K | -48.0% |
| Investing Cash Flow | -$6.2M | +12.7% |
| Financing Cash Flow | $15.2M | +241.2% |
| Free Cash Flow | -$14.1M | -274.0% |
| -133.8% |
| Stockholders' Equity |
| $25.0M |
| -27.5% |